| Defective NKT cell development in mice and humans lacking the adapter SAP, the X-linked lymphoproliferative syndrome gene product B Pasquier, L Yin, MC Fondanèche, F Relouzat, C Bloch-Queyrat, ... The Journal of experimental medicine 201 (5), 695-701, 2005 | 424 | 2005 |
| Erosion of the chronic myeloid leukaemia stem cell pool by PPARγ agonists S Prost, F Relouzat, M Spentchian, Y Ouzegdouh, J Saliba, G Massonnet, ... Nature 525 (7569), 380-383, 2015 | 281 | 2015 |
| Molecular dissection of 2B4 signaling: implications for signal transduction by SLAM-related receptors R Chen, F Relouzat, R Roncagalli, A Aoukaty, R Tan, S Latour, A Veillette Molecular and cellular biology, 2004 | 151 | 2004 |
| Regulation of natural cytotoxicity by the adaptor SAP and the Src-related kinase Fyn C Bloch-Queyrat, MC Fondanèche, R Chen, L Yin, F Relouzat, A Veillette, ... The Journal of experimental medicine 202 (1), 181-192, 2005 | 145 | 2005 |
| Pioglitazone together with imatinib in chronic myeloid leukemia: A proof of concept study P Rousselot, S Prost, J Guilhot, L Roy, G Etienne, L Legros, ... Cancer 123 (10), 1791-1799, 2017 | 93 | 2017 |
| Human and simian immunodeficiency viruses deregulate early hematopoiesis through a Nef/PPARγ/STAT5 signaling pathway in macaques S Prost, M Le Dantec, S Augé, R Le Grand, S Derdouch, G Auregan, ... The Journal of clinical investigation 118 (5), 1765-1775, 2008 | 86 | 2008 |
| Impaired Ig class switch in mice deficient for the X-linked lymphoproliferative disease gene Sap U Al-Alem, C Li, N Forey, F Relouzat, MC Fondanèche, SV Tavtigian, ... Blood 106 (6), 2069-2075, 2005 | 61 | 2005 |
| COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical models P Maisonnasse, Y Aldon, A Marc, R Marlin, N Dereuddre-Bosquet, ... Nature communications 12 (1), 6097, 2021 | 46 | 2021 |
| Patient-derived monoclonal antibody neutralizes SARS-CoV-2 Omicron variants and confers full protection in monkeys C Fenwick, P Turelli, D Ni, L Perez, K Lau, C Herate, R Marlin, E Lana, ... Nature microbiology 7 (9), 1376-1389, 2022 | 36 | 2022 |
| Targeting SARS-CoV-2 receptor-binding domain to cells expressing CD40 improves protection to infection in convalescent macaques R Marlin, V Godot, S Cardinaud, M Galhaut, S Coleon, S Zurawski, ... Nature communications 12 (1), 5215, 2021 | 28 | 2021 |
| Antiviral efficacy of favipiravir against Zika and SARS-CoV-2 viruses in non-human primates R Marlin, D Desjardins, V Contreras, G Lingas, C Solas, P Roques, ... Nature Communications 13 (1), 5108, 2022 | 18 | 2022 |
| Transplantation of Macaca cynomolgus iPS-derived hematopoietic cells in NSG immunodeficient mice S Abed, A Tubsuwan, P Chaichompoo, IH Park, A Pailleret, A Benyoucef, ... Haematologica 100 (10), e428, 2015 | 16 | 2015 |
| Stem cell factor-displaying simian immunodeficiency viral vectors together with a low conditioning regimen allow for long-term engraftment of gene-marked autologous … E Verhoeyen, F Relouzat, M Cambot, C Costa, D Negre, F Legrand, ... Human gene therapy 23 (7), 754-768, 2012 | 14 | 2012 |
| Sotrovimab retains activity against SARS-CoV-2 Omicron variant BQ. 1.1 in a non-human primate model C Hérate, R Marlin, F Touret, N Dereuddre-Bosquet, F Donati, F Relouzat, ... Heliyon 9 (6), 2023 | 11 | 2023 |
| Immunization with synthetic SARS-CoV-2 S glycoprotein virus-like particles protects macaques from infection G Sulbaran, P Maisonnasse, A Amen, G Effantin, D Guilligay, ... Cell Reports Medicine 3 (2), 2022 | 10 | 2022 |
| Targeting STAT5 expression resulted in molecular response improvement in patients with chronic phase CML treated with imatinib P Rousselot, L Roy, G Etienne, L Legros, A Charbonnier, V Coiteux, ... Blood 120 (21), 696, 2012 | 7 | 2012 |
| Functional specialization of short-lived and long-lived macrophage subsets in human tonsils L Alaoui, J Villar, R Leclere, S Le Gallou, F Relouzat, HA Michaud, K Tarte, ... Journal of Experimental Medicine 220 (7), e20230002, 2023 | 5 | 2023 |
| Computed tomography and [18F]-FDG PET imaging provide additional readouts for COVID-19 pathogenesis and therapies evaluation in non-human primates T Naninck, N Kahlaoui, J Lemaitre, P Maisonnasse, A De Mori, Q Pascal, ... Iscience 25 (4), 2022 | 5 | 2022 |
| SARS‐CoV‐2‐related bat virus behavior in human‐relevant models sheds light on the origin of COVID‐19 S Temmam, X Montagutelli, C Herate, F Donati, B Regnault, M Attia, ... EMBO reports 24 (4), e56055, 2023 | 4 | 2023 |
| Durable immunogenicity, adaptation to emerging variants, and low-dose efficacy of an AAV-based COVID-19 vaccine platform in macaques N Zabaleta, U Bhatt, C Hérate, P Maisonnasse, J Sanmiguel, C Diop, ... Molecular Therapy 30 (9), 2952-2967, 2022 | 4 | 2022 |
